We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Source of Very Cold Electrons Designed to Improve Quality, Speed of Nanoimaging for Drug and Materials Development

By LabMedica International staff writers
Posted on 18 Aug 2011
Australian scientists reported that a new cold electron source offers potential advances in electron imaging at the atomic or nanoscale that should have real applications in a range of industries including health.

The study’s findings were published online July 31, 2011, in the journal Nature Physics. More...
Associate Prof. Robert Scholten from School of Physics at the University of Melbourne (Australia) and the University’s ARC Center of Excellence for Coherent X-ray Science (CXS), said, “Enhanced nanoimaging using this cold source will enable us to design better drugs for more targeted treatments. Having a better visibility of the structure of a cell membrane protein, and how it functions will assist in more targeted drug design. It will also help us understand how vulnerabilities such as cracks form, when designing new materials for advanced technology such as in turbine blades for jet engines. Nano imaging using electron microscopy give us intricate images of the micro and nanoscale world, but conventional hot electron sources are incoherent-like the indirect light of light bulbs versus direct laser beams. Depending on the target, it can take several minutes to several hours to undergo this process and the image is not very clear. Our experiments have revealed that with cold electrons and our new technology, we will be able to take a snapshot of the whole sample with atomic resolution and to reduce the imaging time to a trillionth of a second,” he said.

The team, led by Assoc. Prof. Scholten, used lasers to cool atoms to a few millionths of a degree above absolute zero and then to extract a beam of extremely cold electrons. Using new technology, they were able to create beams in complex shapes, and because the electrons are so very cold (about 10 K) the beam retains that shape, rather than exploding as it would for a conventional hot electron source. “This new cold source will allow us to see dynamic processes within the sample, to understand how it functions on a more precise level,” he said. “Cold electron technology opens up a whole new world of imaging--this study is the first to show its real potential.”

The researchers envision that the technology will be further developed in the next few years.

Related Links:

University of Melbourne ARC Center of Excellence for Coherent X-ray Science




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.